Crossmark

First report of a comparative patient-oriented perspective on the use of non-vitamin-K oral anticoagulants or vitamin-K antagonists in atrial fibrillation: patients’ experiences, side-effects and practical problems leading to non-adherence

Crossref DOI link: https://doi.org/10.1007/s12471-019-01331-x

Published Online: 2019-11-19

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bennaghmouch, N.

de Veer, A. J. W. M.

Zivelonghi, C.

van Dijk, L.

ten Berg, J. M.
License Information

Text and Data Mining valid from 2019-11-19

Version of Record valid from 2019-11-19
More Information

Article History

First Online: 19 November 2019

Change Date: 16 April 2021

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s12471-021-01577-4

Conflict of interest

: A.J.W.M. de Veer reports advisory/consulting/speakers’ fees from Bayer and Boehringer Ingelheim. L. van Dijk has received a grant from Bristol-Myers Squibb and Pfizer for the development of the questionnaire described in this article. She received funding from Pfizer, AbbVie and Astra Zeneca for research not related to this study. J.M. ten Berg reports advisory/consulting/speakers’ fees from Accumetrics, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, The Medicines Company and Pfizer, and research grants from AstraZeneca and ZonMw. N. Bennaghmouch and C. Zivelonghi declare that they have no competing interests.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Updates are available Correction dated 2021-04-16

Click to view Correction: https://doi.org/10.1007/s12471-021-01577-4